Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Michael Marafelias"'
Autor:
Adnan Danish, Alexandra Della Pia, Lindsay Fogel, Hassan Alkhatatneh, Charles Zhao, Tony Varughese, Karine A. Al Feghali, Lauren Pascual, Brittany Sinclaire, Michael Marafelias, Joshua Zenreich, Yen-Hong Kuo, Tatyana A. Feldman, Yi Zhang, Andre H. Goy, Andrew Ip, Scott D. Rowley
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Background and purposeThe aim of this study was to determine the prevalence of patients with relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL) meeting high-risk criteria for early relapse after CD19 CAR T-cell therapy (CART) who have disease en
Externí odkaz:
https://doaj.org/article/8182706d74724ca58c0b8faeef2b98b0
Autor:
Andrew Ip, Jaeil Ahn, Yizhao Zhou, Andre H. Goy, Eric Hansen, Andrew L. Pecora, Brittany A. Sinclaire, Urszula Bednarz, Michael Marafelias, Ihor S. Sawczuk, Joseph P. Underwood, David M. Walker, Rajiv Prasad, Robert L. Sweeney, Marie G. Ponce, Samuel La Capra, Frank J. Cunningham, Arthur G. Calise, Bradley L. Pulver, Dominic Ruocco, Greggory E. Mojares, Michael P. Eagan, Kristy L. Ziontz, Paul Mastrokyriakos, Stuart L. Goldberg
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Hydroxychloroquine has not been associated with improved survival among hospitalized COVID-19 patients in the majority of observational studies and similarly was not identified as an effective prophylaxis following exposure in a p
Externí odkaz:
https://doaj.org/article/ee1b97b094224b4a8a84fdfe9518374e
Autor:
Ronaldo C. Go, MD, Roshan Shah, MD, Themba Nyirenda, PHD, Yukiko Oe, MD, Khurram Sarfraz, MD, Justin J. Panthappattu, MD, Lesley Philip, MD, Chandni Bheeman, DO, Neel Shah, DO, Sapan Shah, MD, Sophia Dar, MD, Sung Hung, MD, Waqas Rahman, MD, Hyun Im, MD, Michael Marafelias, Karan Omidvari, MD, Anuja Pradhan, MD, Sean Sadikot, MD, Keith M. Rose, MD, Steven J. Sperber, MD, Joshua Josephs, MD
Publikováno v:
Critical Care Explorations, Vol 3, Iss 7, p e0493 (2021)
OBJECTIVES:. To determine methylprednisolone’s dose, duration, and administration from onset of symptoms and association with 60 days in hospital survival of coronavirus disease 2019 pneumonia. DESIGN:. Cohort study. SETTING:. Thirteen hospitals in
Externí odkaz:
https://doaj.org/article/a4c826ca356a4bd6960f15ac7699c4f6
Autor:
Donald A Berry, Andrew Ip, Brett E Lewis, Scott M Berry, Nicholas S Berry, Mary MrKulic, Virginia Gadalla, Burcu Sat, Kristen Wright, Michelle Serna, Rashmi Unawane, Katerina Trpeski, Michael Koropsak, Puneet Kaur, Zachary Sica, Andrew McConnell, Urszula Bednarz, Michael Marafelias, Andre H Goy, Andrew L Pecora, Ihor S Sawczuk, Stuart L Goldberg
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0255228 (2021)
ObjectivesThe development of a prognostic mortality risk model for hospitalized COVID-19 patients may facilitate patient treatment planning, comparisons of therapeutic strategies, and public health preparations.MethodsWe retrospectively reviewed the
Externí odkaz:
https://doaj.org/article/0544c34f8de74d10831452a6e428d4c2
Autor:
Andrew Ip, Donald A Berry, Eric Hansen, Andre H Goy, Andrew L Pecora, Brittany A Sinclaire, Urszula Bednarz, Michael Marafelias, Scott M Berry, Nicholas S Berry, Shivam Mathura, Ihor S Sawczuk, Noa Biran, Ronaldo C Go, Steven Sperber, Julia A Piwoz, Bindu Balani, Cristina Cicogna, Rani Sebti, Jerry Zuckerman, Keith M Rose, Lisa Tank, Laurie G Jacobs, Jason Korcak, Sarah L Timmapuri, Joseph P Underwood, Gregory Sugalski, Carol Barsky, Daniel W Varga, Arif Asif, Joseph C Landolfi, Stuart L Goldberg
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237693 (2020)
Hydroxychloroquine has been touted as a potential COVID-19 treatment. Tocilizumab, an inhibitor of IL-6, has also been proposed as a treatment of critically ill patients. In this retrospective observational cohort study drawn from electronic health r
Externí odkaz:
https://doaj.org/article/0eb4769173b44ac7b0878cbcbb1584b3
Autor:
Shaked Lev‐Ari, Michael Serzan, Tianmin Wu, Andrew Ip, Lauren Pascual, Brittany Sinclaire, Shari Adams, Michael Marafelias, Lakshmi Ayyagari, Sarvarinder K. Gill, Barbara Ma, Jacob P. Zaemes, Alexandra Della Pia, Adil Alaoui, Subha Madhavan, Anas Belouali, Andrew Pecora, Jaeil Ahn, Michael B. Atkins, Neil J. Shah
Publikováno v:
Cancer. 129:1885-1894
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94b66dcbe91fe1a4ed4a177657f0a5fb
https://doi.org/10.1002/cncr.34742
https://doi.org/10.1002/cncr.34742
Autor:
Sung Hung, Waqas Rahman, Khurram Sarfraz, Yukiko Oe, Joshua Josephs, Justin J. Panthappattu, Steven J. Sperber, Sean Sadikot, Sapan Shah, Ronaldo C. Go, Karan Omidvari, Hyun Im, Themba Nyirenda, Lesley Philip, Anuja Pradhan, Sophia Dar, Michael Marafelias, DO Chandni Bheeman, Roshan Shah, DO Neel Shah, Keith M. Rose
Publikováno v:
Critical Care Explorations
Crit Care Explor
Critical Care Explorations, Vol 3, Iss 7, p e0493 (2021)
Crit Care Explor
Critical Care Explorations, Vol 3, Iss 7, p e0493 (2021)
Supplemental Digital Content is available in the text.
OBJECTIVES: To determine methylprednisolone’s dose, duration, and administration from onset of symptoms and association with 60 days in hospital survival of coronavirus disease 2019 pneumo
OBJECTIVES: To determine methylprednisolone’s dose, duration, and administration from onset of symptoms and association with 60 days in hospital survival of coronavirus disease 2019 pneumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6cda4c0cd81670f85a1e49a75663399
http://europepmc.org/articles/PMC8291358
http://europepmc.org/articles/PMC8291358
Autor:
Scott M. Berry, Brett E. Lewis, Virginia Gadalla, Michael Marafelias, Andrew McConnell, Andrew Ip, Andrew L. Pecora, Donald A. Berry, Ihor S. Sawczuk, Puneet Kaur, Zachary Sica, Urszula Bednarz, Michael Koropsak, Mary Mrkulic, Michelle Serna, Burcu Sat, Stuart L. Goldberg, Kristen Wright, Katerina Trpeski, Nicholas S. Berry, Rashmi Unawane, Andre Goy
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0255228 (2021)
BASE-Bielefeld Academic Search Engine
PLoS ONE
BASE-Bielefeld Academic Search Engine
PLoS ONE
Objectives The development of a prognostic mortality risk model for hospitalized COVID-19 patients may facilitate patient treatment planning, comparisons of therapeutic strategies, and public health preparations. Methods We retrospectively reviewed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d320ccac87cf9fc5cf0e4d6e09f225b
https://doaj.org/article/0544c34f8de74d10831452a6e428d4c2
https://doaj.org/article/0544c34f8de74d10831452a6e428d4c2
Autor:
Eric Hansen, Roman A Tuma, David S. Siegel, Aaron A Stein, Noa Biran, Valerie R.C. Allusson, Eric J Costanzo, Michael Marafelias, Lauren S Koniaris, Ronaldo C. Go, Vincent Vivona, George S Lin, Lisa Tank, Micky Simwenyi, Jaeil Ahn, Andre Goy, Andrew L. Pecora, Ihor S. Sawczuk, Joseph Reichman, William F Oser, Kim L Carpenter, Shivam Mathura, Louis Brusco, Urszula Bednarz, Stuart L. Goldberg, Brittany A Sinclaire, Shuqi Wang, Andrew Ip, Daniel W Varga
Publikováno v:
The Lancet Rheumatology
Summary Background Tocilizumab, a monoclonal antibody directed against the interleukin-6 receptor, has been proposed to mitigate the cytokine storm syndrome associated with severe COVID-19. We aimed to investigate the association between tocilizumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b45a8ce6c8f0574e260475f6ffd3fdd
Autor:
Eric Hansen, Samuel La Capra, Ihor S. Sawczuk, Greggory E. Mojares, Michael Marafelias, Arthur Calise, Brittany A Sinclaire, Bradley L. Pulver, Andrew L. Pecora, Joseph P. Underwood, Andrew Ip, Frank J. Cunningham, Jaeil Ahn, Marie G. Ponce, Robert L. Sweeney, Dominic Ruocco, David M Walker, Rajiv Prasad, Yizhao Zhou, Paul Mastrokyriakos, Stuart L. Goldberg, Kristy L. Ziontz, Michael P. Eagan, Urszula Bednarz, Andre Goy
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
BackgroundHydroxychloroquine has not been associated with improved survival among hospitalized COVID-19 patients in the majority of observational studies and similarly was not identified as an effective prophylaxis following exposure in a prospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d441f1d43e8919063ba30fa9b357ee15
https://doi.org/10.1101/2020.08.20.20178772
https://doi.org/10.1101/2020.08.20.20178772
